Inhaled nitric oxide as an independent intervention to lower the risk of bronchopulmonary dysplasia in preterm infants (< 33 weeks) with pulmonary hypertension within the initial 3 days of life

Inhaled nitric oxide as an independent intervention to lower the risk of bronchopulmonary dysplasia in preterm infants (< 33 weeks) with pulmonary hypertension within the initial 3 days of life

Abstract Bronchopulmonary dysplasia (BPD) is a major complication in preterm infants, particularly those born before 33 weeks of gestation. Inhaled nitric oxide (iNO) is widely used to manage pulmonary hypertension (PH) and improve oxygenation, but its role in reducing BPD incidence in preterm infan...

Full description

Saved in:
Bibliographic Details
Main Authors: Tasnim Azad, Li Li, Shuo Wang, ShaoJie Yue, XiaoHe Yu, ZhengChang Liao, ChuanDing Cao, Ying Ding, Mei Lv, Teng Liu, MeiYan Chu, MingJie Wang
Format: Article
Language:English
Published: Nature Portfolio 2025-07-01
Series:Scientific Reports
Subjects:
Bronchopulmonary dysplasia
Preterm infants
Inhaled nitric oxide
Pulmonary surfactant
Pulmonary hypertension
Online Access:https://doi.org/10.1038/s41598-025-06055-0
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1038/s41598-025-06055-0

Similar Items